Doxylamine Succinate And Pyridoxine Hydrochloride recalls
Doxylamine Succinate And Pyridoxine Hydrochloride products have been recalled 2 times, most recently on 9 Sep 2026. The recalling company is usually Bionpharma. The most common reason is potency & assay.
Total recalls2since 2022
Last 12 months1reported
Class I00% of total
Ongoing1latest 9 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why doxylamine succinate and pyridoxine hydrochloride is recalled
Companies
By year
Ongoing doxylamine succinate and pyridoxine hydrochloride recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Doxylamine Succinate and Pyridoxine HCl Delayed-Release recalledDoxylamine Succinate And Pyridoxine Hydrochloride | Bionpharma | Other | Nationwide |
All doxylamine succinate and pyridoxine hydrochloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Doxylamine Succinate and Pyridoxine HCl Delayed-Release recalledDoxylamine Succinate And Pyridoxine Hydrochloride | Bionpharma | Other | Nationwide |
| Drug | CLASS II | Doxylamine Succinate and Pyridoxine Hydrochloride recalledDoxylamine Succinate And Pyridoxine Hydrochloride | Teva Pharmaceuticals USA | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.